DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
51 hedge funds and large institutions have $9.69M invested in DMK Pharmaceuticals Corporation Common Stock in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
59% less call options, than puts
Call options by funds: $85K | Put options by funds: $209K
Holders
51
Holding in Top 10
–
Calls
$85K
Puts
$209K
Top Buyers
| 1 | +$644K | |
| 2 | +$181K | |
| 3 | +$101K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$47.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.7K |
Top Sellers
| 1 | -$3.36M | |
| 2 | -$2.55M | |
| 3 | -$364K | |
| 4 |
Millennium Management
New York
|
-$194K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$136K |